Schizophrenia.com
FDA Approves VRAYLAR as Adjunctive Therapy for Major Depressive Disorder and AbbVie Announces Reimbursement Program in Canada
Medications
everhopeful
June 7, 2023, 2:14pm
1
1 Like
Related topics
Topic
Replies
Views
Activity
AbbVie Announces Provincial Reimbursement for VRAYLAR® (cariprazine) for the Treatment of Schizophrenia in Québec
Medications
1
296
April 17, 2023
AbbVie Submits Cariprazine FDA Application for Major Depressive Disorder
Medications
1
255
June 11, 2022
Vraylar / cariprazine approved for MDD
News
2
275
December 17, 2022
VRAYLAR available in pharmacies!
News
15
3095
March 14, 2017
Vraylar wins FDA approval for bipolar depression
News
0
303
May 29, 2019